{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T21:07:15Z","timestamp":1782940035288,"version":"3.54.5"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.anndiagpath.2024.152383","type":"journal-article","created":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T23:08:38Z","timestamp":1728688118000},"page":"152383","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Clinicopathological analysis of primary central nervous system lymphoma in patients with or without HIV infection"],"prefix":"10.1016","volume":"73","author":[{"given":"Man","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enshan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangmei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haili","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.anndiagpath.2024.152383_bb0005","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1038\/s41467-022-30050-y","article-title":"The genomic and transcriptional landscape of primary central nervous system lymphoma[J]","volume":"13","author":"Radke","year":"2022","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.anndiagpath.2024.152383_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2020.153192","article-title":"HIV prevalence in primary central nervous system lymphoma: a systematic review and meta-analysis[J]","volume":"216","author":"Franca","year":"2020","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.anndiagpath.2024.152383_bb0015","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/B978-0-444-63849-6.00014-1","article-title":"Primary CNS lymphoma in HIV infection[J]","volume":"152","author":"Brandsma","year":"2018","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.anndiagpath.2024.152383_bb0020","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ijid.2021.10.023","article-title":"Differentiation of acquired immune deficiency syndrome related primary central nervous system lymphoma from cerebral toxoplasmosis with use of susceptibility-weighted imaging and contrast enhanced 3D-T1WI[J]","volume":"113","author":"Li","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"16","key":"10.1016\/j.anndiagpath.2024.152383_bb0025","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/jnci\/djt158","article-title":"Temporal trends in presentation and survival for HIV-associated lymphoma in the antiretroviral therapy era[J]","volume":"105","author":"Gopal","year":"2013","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.anndiagpath.2024.152383_bb0030","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s10552-019-01144-8","article-title":"Primary central nervous system lymphoma in patients with and without HIV infection: a multicenter study and comparison with U.S national data[J]","volume":"30","author":"Dandachi","year":"2019","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.anndiagpath.2024.152383_bb0035","first-page":"36(7)","article-title":"The 5th edition of the World Health Organization classification of Haematolymphoid Tumours: lymphoid neoplasms[J]","volume":"2022","author":"Alaggio","year":"1720","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.anndiagpath.2024.152383_bb0040","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray[J]","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.anndiagpath.2024.152383_bb0045","first-page":"1","article-title":"Complete proteinogram of cerebrospinal fluid and its contribution to the diagnostics of inflammatory and autoimmune diseases of the central nervous system[J]","volume":"104","author":"Adam","year":"2003","journal-title":"Sb Lek"},{"issue":"2","key":"10.1016\/j.anndiagpath.2024.152383_bb0050","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s11060-010-0252-3","article-title":"Primary CNS lymphoma in HIV positive and negative patients: comparison of clinical characteristics, outcome and prognostic factors[J]","volume":"101","author":"Bayraktar","year":"2011","journal-title":"J Neurooncol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2024.152383_bb0055","doi-asserted-by":"crossref","first-page":"20","DOI":"10.14791\/btrt.2020.8.e7","article-title":"A National Consensus Survey for current practice in brain tumor management III: brain metastasis and primary central nervous system lymphoma[J]","volume":"8","author":"Kim","year":"2020","journal-title":"Brain Tumor Res Treat"},{"issue":"12","key":"10.1016\/j.anndiagpath.2024.152383_bb0060","doi-asserted-by":"crossref","first-page":"6124","DOI":"10.1002\/cam4.1820","article-title":"Lactate dehydrogenase a: a key player in carcinogenesis and potential target in cancer therapy[J]","volume":"7","author":"Feng","year":"2018","journal-title":"Cancer Med"},{"key":"10.1016\/j.anndiagpath.2024.152383_bb0065","doi-asserted-by":"crossref","DOI":"10.1177\/20406207211066166","article-title":"Primary central nervous system lymphoma in the United States, 1975-2017[J]","volume":"13","author":"Lv","year":"2022","journal-title":"Ther Adv Hematol"},{"key":"10.1016\/j.anndiagpath.2024.152383_bb0070","doi-asserted-by":"crossref","first-page":"17","DOI":"10.21037\/sci-2023-021","article-title":"Primary central nervous system lymphoma: treatment access and outcomes in HIV positive patients in a minority rich cohort[J]","volume":"10","author":"Narvel","year":"2023","journal-title":"Stem Cell Investig"},{"issue":"3","key":"10.1016\/j.anndiagpath.2024.152383_bb0075","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S1474-4422(07)70034-0","article-title":"Serial MRI to determine the effect of dexamethasone on the cerebral pathology of tuberculous meningitis: an observational study[J]","volume":"6","author":"Thwaites","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.anndiagpath.2024.152383_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2021.106838","article-title":"MYC, BCL2, and BCL6 expression as prognostic indicators in primary central nervous system lymphoma: a systematic review and meta-analysis[J]","volume":"208","author":"Ge","year":"2021","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"10.1016\/j.anndiagpath.2024.152383_bb0085","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13000-023-01413-w","article-title":"The expression and clinical significance of PLK1\/p-PLK1 protein in NK\/T cell lymphoma[J]","volume":"18","author":"Zhang","year":"2023","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.anndiagpath.2024.152383_bb0090","series-title":"New genetic prognostic biomarkers in primary central nervous system lymphoma","first-page":"e02061","volume":"vol. 11(4)","author":"Gomes Candido Reis","year":"2021"},{"issue":"12","key":"10.1016\/j.anndiagpath.2024.152383_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0295944","article-title":"The p53 protein is a suppressor of Atox1 copper chaperon in tumor cells under genotoxic effects[J]","volume":"18","author":"Tsymbal","year":"2023","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.anndiagpath.2024.152383_bb0100","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00401-023-02613-w","article-title":"Integrated genetic analyses of immunodeficiency-associated Epstein-Barr virus- (EBV) positive primary CNS lymphomas[J]","volume":"146","author":"Kaulen","year":"2023","journal-title":"Acta Neuropathol"},{"issue":"24","key":"10.1016\/j.anndiagpath.2024.152383_bb0105","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01390-20","article-title":"Epstein-Barr virus Episome physically interacts with active regions of the host genome in Lymphoblastoid cells[J]","volume":"94","author":"Wang","year":"2020","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.anndiagpath.2024.152383_bb0110","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/CCO.0000000000000978","article-title":"Pathology and new insights in central nervous system lymphomas[J]","volume":"35","author":"Lebrun","year":"2023","journal-title":"Curr Opin Oncol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2024.152383_bb0115","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","article-title":"The role of m6A modification in the biological functions and diseases[J]","volume":"6","author":"Jiang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"10.1016\/j.anndiagpath.2024.152383_bb0120","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.molcel.2016.03.021","article-title":"The m(6)a methyltransferase METTL3 promotes translation in human Cancer cells[J]","volume":"62","author":"Lin","year":"2016","journal-title":"Mol Cell"},{"issue":"4","key":"10.1016\/j.anndiagpath.2024.152383_bb0125","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/onc.2017.351","article-title":"Essential role of METTL3-mediated m(6)a modification in glioma stem-like cells maintenance and radioresistance[J]","volume":"37","author":"Visvanathan","year":"2018","journal-title":"Oncogene"},{"issue":"56","key":"10.1016\/j.anndiagpath.2024.152383_bb0130","doi-asserted-by":"crossref","first-page":"96103","DOI":"10.18632\/oncotarget.21726","article-title":"The M6A methyltransferase METTL3: acting as a tumor suppressor in renal cell carcinoma[J]","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.anndiagpath.2024.152383_bb0135","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3748\/wjg.v10.i4.509","article-title":"Genes encoding Pir51, Beclin 1, RbAp48 and aldolase b are up or down-regulated in human primary hepatocellular carcinoma[J]","volume":"10","author":"Song","year":"2004","journal-title":"World J Gastroenterol"},{"issue":"19","key":"10.1016\/j.anndiagpath.2024.152383_bb0140","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1016\/j.molcel.2021.07.037","article-title":"Mechanism of noncoding RNA-associated N-methyladenosine recognition by an RNA processing complex during DNA recombination[J]","volume":"81","author":"Nair","year":"2021","journal-title":"Mol Cell"},{"issue":"4","key":"10.1016\/j.anndiagpath.2024.152383_bb0145","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1021\/acsbiomedchemau.3c00023","article-title":"Structure-based Design of Inhibitors of the m6A-RNA writer enzyme METTL3[J]","volume":"3","author":"Bedi","year":"2023","journal-title":"ACS Bio & Med Chem Au"},{"key":"10.1016\/j.anndiagpath.2024.152383_bb0150","doi-asserted-by":"crossref","first-page":"16011","DOI":"10.1038\/nmicrobiol.2016.11","article-title":"Dynamics of the human and viral m(6)a RNA methylomes during HIV-1 infection of T cells[J]","volume":"1","author":"Lichinchi","year":"2016","journal-title":"Nat Microbiol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2024.152383_bb0155","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1182\/blood-2005-03-1024","article-title":"A uniform activated B-cell-like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases[J]","volume":"107","author":"Camilleri-Broet","year":"2006","journal-title":"Blood"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913424001205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913424001205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T06:29:50Z","timestamp":1731652190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913424001205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":31,"alternative-id":["S1092913424001205"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2024.152383","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinicopathological analysis of primary central nervous system lymphoma in patients with or without HIV infection","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2024.152383","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152383"}}